Advanced search
Publication Cover
Leukemia & Lymphoma Volume 35, 1999 - Issue 5-6
Submit an article Journal homepage
96
Views
38
CrossRef citations to date
0
Altmetric
Original Article

Five Years Follow-Up after 2-Chloro Deoxyadenosine Treatment in Thirty Patients with Hairy Cell Leukemia: Evaluation of Minimal Residual Disease and CD4+ Lymphocytopenia after Treatment

J. N. Bastie Service d'hématologie. Centre hospitaller de Versailles, Le Chesnay
,
D. Cazals-Hatem Institut des Recherches sur les Maladies du Sang, Hôpital, Saint Louis, Paris
,
M. T. Daniel Institut des Recherches sur les Maladies du Sang, Hôpital, Saint Louis, Paris
,
M. F. D'agay Institut des Recherches sur les Maladies du Sang, Hôpital, Saint Louis, Paris
,
CL. Rabian Institut des Recherches sur les Maladies du Sang, Hôpital, Saint Louis, Paris
,
S. Glaisner Institut des Recherches sur les Maladies du Sang, Hôpital, Saint Louis, Paris
,
M. P. Noel-Walter Departement d'hématologie, Hôpital Huriez, Lille
,
D. Dabout Laboratoire Janssen-Cilag, Issy-les-Moulineaux, France
,
G. Flandrin Laboratoire d'hématologie, Hôpital, Necker, Paris
,
H. Dombret Institut des Recherches sur les Maladies du Sang, Hôpital, Saint Louis, Paris
,
D. Poisson Laboratoire Janssen-Cilag, Issy-les-Moulineaux, France
,
L. Degos Institut des Recherches sur les Maladies du Sang, Hôpital, Saint Louis, Paris
&
S. Castaigne Service d'hématologie. Centre hospitaller de Versailles, Le Chesnay
 show all
Pages 555-565 | Received 30 Mar 1999, Published online: 30 Mar 2010

Citations (38)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Janice Haynes, Maria Jackson & Steven S. Smugar. (2022) Increased risk of severe cutaneous adverse reactions when cladribine is used together with other medications with a propensity for skin reactions. Leukemia & Lymphoma 63:12, pages 2965-2974.
Read now
Zheng Z Topp & Alan Saven. (2014) Hairy cell leukemia: a ‘hair-raising’ update. Expert Review of Hematology 7:5, pages 659-669.
Read now
Jae H. Park & Martin S. Tallman. (2014) Left behind: should minimal residual disease be treated in hairy cell leukemia?. Leukemia & Lymphoma 55:5, pages 971-972.
Read now
Estella Matutes. (2013) Orphan drugs for the treatment of hairy cell leukemia. Expert Opinion on Orphan Drugs 1:1, pages 21-31.
Read now
Reza Setoodeh & Ling Zhang. (2012) Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature. Leukemia & Lymphoma 53:4, pages 736-738.
Read now
Jan-Paul de Boer, Markus Raderer, Harm van Tinteren, Berthe M. P. Aleman, Henk Boot & Daphne de Jong. (2011) Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment. Leukemia & Lymphoma 52:12, pages 2262-2269.
Read now
Martin S. Tallman. (2011) Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping. Leukemia & Lymphoma 52:sup2, pages 65-68.
Read now
Constantin A Dasanu, TE Ichim & Doru T Alexandrescu. (2010) Inherent and iatrogenic immune defects in hairy cell leukemia: revisited. Expert Opinion on Drug Safety 9:1, pages 55-64.
Read now
Constantin A Dasanu & Doru T Alexandrescu. (2010) Risk of additional cancers in untreated and treated hairy cell leukemia patients. Expert Opinion on Pharmacotherapy 11:1, pages 41-50.
Read now
Deborah A. Thomas, Farhad Ravandi, Michael Keating & Hagop M. Kantarjian. (2009) Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy. Leukemia & Lymphoma 50:sup1, pages 27-31.
Read now
Robert J. Kreitman, David J. P. Fitzgerald & Ira Pastan. (2009) Approach to the patient after relapse of hairy cell leukemia. Leukemia & Lymphoma 50:sup1, pages 32-37.
Read now

Articles from other publishers (27)

Elsa Maitre, Jerome Paillassa & Xavier Troussard. (2022) Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders. Frontiers in Oncology 12.
Crossref
Jérôme Paillassa, Elsa Maitre & Xavier Troussard. (2022) Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances. Current Oncology Reports 24:9, pages 1133-1143.
Crossref
Jérôme Paillassa & Xavier Troussard. (2021) Patients with relapsed/refractory hairy‐cell leukemia. Cancer Reports 5:3.
Crossref
Jerome Paillassa, Edouard Cornet, Stephanie Noel, Cecile Tomowiak, Stephane Lepretre, Sandrine Vaudaux, Jehan Dupuis, Alain Devidas, Bertrand Joly, Charlotte Petitdidier-Lionnet, Stephanie Haiat, Clara Mariette, Catherine Thieblemont, Didier Decaudin, Patricia Validire-Charpy, Bernard Drenou, Jean-Claude Eisenmann, Mario Ojeda Uribe, Agnès Olivrie, Mohamed Touati, Olivier Lambotte, Olivier Hermine, Jean-Michel Karsenti, Pierre Feugier, Willy Vaillant, Jean Gutnecht, Eric Lippert, Fabienne Huysman, Kamel Ghomari, Marouane Boubaya, Vincent Levy, Jeremie Riou, Gandhi Damaj, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Xavier Troussard. (2020) Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up. Blood Cancer Journal 10:5.
Crossref
Karl B. Alstadhaug, Randi Fykse Halstensen & Francis Odeh. (2017) Progressive multifocal leukoencephalopathy in a patient with systemic mastocytosis treated with cladribine. Journal of Clinical Virology 88, pages 17-20.
Crossref
Frank J Senatore & Constantin A Dasanu. (2015) Synchronous gastric and ampullary adenocarcinomas in a hairy cell leukemia patient treated with pentostatin eight years prior. Journal of Oncology Pharmacy Practice 22:3, pages 543-547.
Crossref
Stéphane Barete, Olivier LortholaryGandhi DamajIsabelle HirschMarie Olivia ChandesrisCaroline ElieMohamed HamidouIsabelle DurieuFelipe SuarezBernard GrosboisNicolas LimalEmmanuel GyanClaire LarrocheGérard GuilletJean Emmanuel KahnPhilippe CasassusKarima AmazzoughHélène Coignard-BiehlerSophie Georgin-LavialleLudovic LhermitteSylvie FraitagDanielle CanioniPatrice DubreuilOlivier Hermine. (2015) Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis. Blood 126:8, pages 1009-1016.
Crossref
Michael R. Grever, James S. Blachly & Leslie A. Andritsos. (2014) Hairy cell leukemia: Update on molecular profiling and therapeutic advances. Blood Reviews 28:5, pages 197-203.
Crossref
Robert J. Kreitman, Wyndham Wilson, Katherine R. Calvo, Evgeny Arons, Laura Roth, Jeffrey Sapolsky, Hong Zhou, Mark Raffeld & Maryalice Stetler-Stevenson. (2013) Cladribine with Immediate Rituximab for the Treatment of Patients with Variant Hairy Cell Leukemia. Clinical Cancer Research 19:24, pages 6873-6881.
Crossref
Hirokazu Nagai, Michinori Ogura, Shigeru Kusumoto, Naoto Takahashi, Motoko Yamaguchi, Nobuyuki Takayama, Tomohiro Kinoshita, Toshiko Motoji, Kazuma Ohyashiki, Hiroshi Kosugi, Shin Matsuda, Kazunori Ohnishi, Ken Omachi & Tomomitsu Hotta. (2011) Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma. European Journal of Haematology 86:2, pages 117-123.
Crossref
Moises A. Huaman, Angel Coz-Yataco, Hiren Pokharna, Lisa Stagner & Marcus J. Zervos. (2011) Severe Case of Legionella pneumophila Pneumonia in the Debut of Hairy Cell Leukemia. Infectious Diseases in Clinical Practice 19:1, pages 64-67.
Crossref
Robert P. Hasserjian. 2011. Hematopathology. Hematopathology 247 255 .
Jean-François Morère, Françoise Mornex & Denis SoulièresS. Castaigne. 2011. Thérapeutique du cancer. Thérapeutique du cancer 837 846 .
Tadeusz Robak, Anna Korycka, Ewa Lech-Maranda & Pawel Robak. (2009) Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases. Molecules 14:3, pages 1183-1226.
Crossref
Ronan Swords & Francis Giles. (2007) Hairy cell leukemia. Medical Oncology 24:1, pages 7-15.
Crossref
Tadeusz Robak. (2006) Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treatment Reviews 32:5, pages 365-376.
Crossref
Sam O. Wanko & Carlos de Castro. (2006) Hairy Cell Leukemia: An Elusive but Treatable Disease. The Oncologist 11:7, pages 780-789.
Crossref
Evgeny Arons, Inger Margulies, Lynn Sorbara, Mark Raffeld, Maryalice Stetler-Stevenson, Ira Pastan & Robert J. Kreitman. (2006) Minimal Residual Disease in Hairy Cell Leukemia Patients Assessed by Clone-Specific Polymerase Chain Reaction. Clinical Cancer Research 12:9, pages 2804-2811.
Crossref
Paulette Mhawech-Fauceglia, Martin Oberholzer, Senait Aschenafi, Audrey Baur, Michael Kurrer, Albert Von Rohr, Shu-Fang Hsu-Schmitz, Beatrice Wagner, Francoise Delacretaz & Nina Hurwitz. (2006) Potential Predictive Patterns of Minimal Residual Disease Detected by Immunohistochemistry on Bone Marrow Biopsy Specimens During a Long-term Follow-up in Patients Treated With Cladribine for Hairy Cell Leukemia. Archives of Pathology & Laboratory Medicine 130:3, pages 374-377.
Crossref
W. Pönisch & D. Niederwieser. (2006) Folgeerkrankungen nach ChemotherapieLate effects after chemotherapy. Der Internist 47:3, pages 266-274.
Crossref
Martin Gramatzki. 2006. Der Fokus im HNO-Bereich: Fakt oder Fiktion?. Der Fokus im HNO-Bereich: Fakt oder Fiktion? 85 94 .
André Tichelli & Gérard Socié. (2005) Considerations for Adult Cancer Survivors. Hematology 2005:1, pages 516-522.
Crossref
A. Klippstein, C. P. Schneider, H. G. Sayer & K. Höffken. (2003) Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. Journal of Cancer Research and Clinical Oncology 129:5, pages 316-319.
Crossref
Aura S Kamiguti, Robert J Harris, Joseph R Slupsky, Peter K Baker, John C Cawley & Mirko Zuzel. (2003) Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways. Oncogene 22:15, pages 2272-2284.
Crossref
Kelly J Bethel & Robert W Sharpe. (2003) Pathology of hairy-cell leukaemia. Best Practice & Research Clinical Haematology 16:1, pages 15-31.
Crossref
Ulrich Mey, John Strehl, Marcus Gorschlüter, Carsten Ziske, Axel Glasmacher, Hans Pralle & Ingo Schmidt-Wolf. (2003) Advances in the treatment of hairy-cell leukaemia. The Lancet Oncology 4:2, pages 86-94.
Crossref
Robert J. Kreitman. (2002) Hairy Cell Leukemia. American Journal of Cancer 1:3, pages 189-203.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.